Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 410-660-5 | CAS number: 1072830-14-8
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Extensive testing and reviews have been conducted on titanium dioxide, triethanolamine and propylene glycol, demonstrating that there is no mutagenic potential.
An IARC monograph on triethanolamine suggests that there is no evidence for mutagenicity, and this is cited in the IUCLID file. WORLD HEALTH ORGANIZATION
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 77
Some Industrial Chemicalshttp://monographs.iarc.fr/ENG/Monographs/vol77/volume77.pdf
Titanium dioxide has been extensively investigated, especially in nano-form for use in cosmetics and several review documents suggest low risk. One citation is in Drug Chemistry and Toxicology, 2011 July 34(3):277-84.Cytotoxicity and genotoxicity of titanium dioxide nanoparticles in UVA-irradiated normal peripheral blood lymphocytes: Kang, Lee et al.
Propylene glycol has also been extensively evaluated and review documents suggest low risk of mutagenic potential. A review by the US EPA (Prevention Pesticides and Toxic Substances, EPA-739-R-06-002, September 2006)
http://www.epa.gov/oppsrrd1/REDs/propylene_glycol_red.pdf
Propylene glycol and dipropylene glycol were tested for mutagenic or genotoxic potential and found to be negative in a battery of studies: a bacterial gene mutation assay using Salmonella typhimurium, and in vitro Chinese hamster ovary (CHO) mutation assay, an in vitro Chinese hamster ovary (CHO) chromosomal aberration assay and an in vitro sister chromatid exchange assay.
Propan-2-ol is reported in a review by the EU Scientific Committee on Health and Environmental Risks conclude low toxic risk (25th plenary on 9 September 2008), but suggests that data is limited with regard to in-vitro mutagenicity evaluation.
Short description of key information:
Negative results in all testing performed and from review of metabolites
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Negative results in all testing performed and from review of metabolites
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
